Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 1
1986 3
1987 3
1988 6
1990 1
1993 1
1994 1
1995 3
1996 2
1997 1
2004 1
2005 2
2006 3
2007 2
2009 2
2010 1
2011 1
2012 2
2013 2
2014 1
2015 2
2016 1
2018 2
2019 1
2021 1
2022 1
2023 2
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for sklodowska m
Search for Sklodwska M instead (1 results)
Real-life degradation of epinephrine in adrenaline autoinjectors: A single-center, 12-month prospective observation.
Lacwik P, Ochab-Krupnik D, Mościcka A, Wielanek M, Wojciechowska M, Skłodowska M, Kupczyk M, Białas AJ, Sleiman Y, Kręcisz B, Czarny-Działak M, Pałczyński C. Lacwik P, et al. Among authors: sklodowska m. J Allergy Clin Immunol Pract. 2024 Dec;12(12):3423-3425.e2. doi: 10.1016/j.jaip.2024.08.026. Epub 2024 Aug 19. J Allergy Clin Immunol Pract. 2024. PMID: 39168301 No abstract available.
Survival of European patients with central nervous system tumors.
Sant M, Minicozzi P, Lagorio S, Børge Johannesen T, Marcos-Gragera R, Francisci S; EUROCARE Working Group. Sant M, et al. Int J Cancer. 2012 Jul 1;131(1):173-85. doi: 10.1002/ijc.26335. Epub 2011 Nov 10. Int J Cancer. 2012. PMID: 21805473
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
du Bois A, Kristensen G, Ray-Coquard I, Reuss A, Pignata S, Colombo N, Denison U, Vergote I, Del Campo JM, Ottevanger P, Heubner M, Minarik T, Sevin E, de Gregorio N, Bidziński M, Pfisterer J, Malander S, Hilpert F, Mirza MR, Scambia G, Meier W, Nicoletto MO, Bjørge L, Lortholary A, Sailer MO, Merger M, Harter P; AGO Study Group led Gynecologic Cancer Intergroup/European Network of Gynaecologic Oncology Trials Groups Intergroup Consortium. du Bois A, et al. Lancet Oncol. 2016 Jan;17(1):78-89. doi: 10.1016/S1470-2045(15)00366-6. Epub 2015 Nov 16. Lancet Oncol. 2016. PMID: 26590673 Free article. Clinical Trial.
46 results